Claims for Patent: 9,732,343

Summary for Patent: 9,732,343

Title:	Composition and method for inner ear sensory hair cell regeneration and replacement
Abstract:	A composition and method for replacement and regeneration of hair cells of the inner ear is provided. The composition comprises an active agent in an amount effective to decrease Hes1 gene expression in a tissue of the inner ear. The active agent can be short interfering RNA (siRNA) molecules encapsulated in a biodegradable nanoparticle. The method involves administering a solution to the inner ear where the solution contains an active agent in an amount effective to decrease Hes1 gene expression.
Inventor(s):	Kopke; Richard D. (Oklahoma City, OK)
Assignee:	HOUGH EAR INSTITUTE (Oklahoma City, OK)
Application Number:	14/803,737
Patent Claims:	1. A composition for regenerating hair cells of the inner ear comprising: (a) magnetically responsive nanoparticles comprising a biodegradable polymer and an siRNA molecule that decreases expression of a MAPK1 gene in a tissue of the inner ear and (b) a pharmaceutically acceptable carrier. 2. The composition of claim 1, wherein the biodegradable polymer is poly(lactic-co-glycolic acid). 3. The composition of claim 1, wherein the nanoparticles comprise superparamagnetic iron oxide. 4. The composition of claim 1, wherein the nanoparticles comprise from about 500 to about 1000 siRNA molecules per nanoparticle. 5. The composition of claim 1, wherein the nanoparticles are dispersed in the pharmaceutically acceptable carrier. 6. The composition of claim 5, in which a concentration of the siRNA molecules per milliliter of dispersion ranges from about 50 .mu.g/mL to about 100 .mu.g/mL. 7. The composition of claim 5, wherein the pharmaceutically acceptable carrier is selected from a group consisting of artificial perilymph, 5% dextrose in sterile water, sterile physiologic saline, and phosphate-buffered physiologic saline. 8. A method of regenerating hair cells of an inner ear of a mammal comprising: applying to the inner ear of a mammal in need thereof an amount of biodegradable nanoparticles comprising an siRNA molecule that decreases expression of a MAPK1 gene in a tissue of the inner ear effective to regenerate hair cells in an inner ear of said mammal. 9. The method of claim 8, wherein the nanoparticles are magnetically responsive. 10. The method of claim 9, wherein the applying comprises using magnetic force to transport the nanoparticles across the round window membrane.

Details for Patent 9,732,343

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	ZOSTAVAX	zoster vaccine live	For Injection	125123	05/25/2006		2030-06-04